Literature DB >> 25788651

Risk Factors for Age-Related Macular Degeneration in an Elderly Japanese Population: The Hatoyama Study.

Aya Aoki1, Xue Tan2, Reiko Yamagishi2, Shoji Shinkai3, Ryo Obata2, Tempei Miyaji4, Takuhiro Yamaguchi5, Jiro Numaga3, Hideki Ito3, Yasuo Yanagi2.   

Abstract

PURPOSE: To estimate the risk factors of AMD in an elderly Japanese population from a suburban area north of metropolitan Tokyo.
METHODS: The Hatoyama Cohort Study was launched in 2010, and 742 persons participated in the baseline study. Among these participants, 596 persons who attended the 2-year follow-up examinations in 2012 were evaluated, and the presence of early and late AMD was determined via grading of their fundus photographs. Based on the cohorts' data, logistic regression analyses were performed to identify the risk factors for AMD. The possible risk factors that we examined were age, sex, medical history of systemic disorders, smoking, inflammatory markers at baseline, and the complement factor H (CFH) I62V and age-related maculopathy susceptibility 2 (ARMS2) A69S variants.
RESULTS: We assessed 480 participants (40.0% women) who had gradable fundus photographs. The prevalence of early AMD was 37.9% and the prevalence of late AMD was 0.6%. Mantel-Haenszel analysis revealed that the CFH I62V and ARMS2 A69S variants were significantly associated with the prevalence of AMD (P = 0.029 and 0.025, respectively).
CONCLUSIONS: The CFH I62V and ARMS2 A69S variants were significantly associated with the prevalence of AMD. (www.umin.ac.jp/ctr number, UMIN000014520.).

Entities:  

Mesh:

Year:  2015        PMID: 25788651     DOI: 10.1167/iovs.14-16339

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  No Sex Differences in the Frequencies of Common Single Nucleotide Polymorphisms Associated with Age-Related Macular Degeneration.

Authors:  Nicholas A Popp; Elvira Agrón; Gregory S Hageman; Jingsheng Tuo; Emily Y Chew; Chi-Chao Chan
Journal:  Curr Eye Res       Date:  2016-07-15       Impact factor: 2.424

2.  Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration.

Authors:  Mariko Yamashita; Masanori Matsumoto; Masaki Hayakawa; Kazuya Sakai; Yoshihiro Fujimura; Nahoko Ogata
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

3.  Associations of ARMS2 and CFH Gene Polymorphisms with Neovascular Age-Related Macular Degeneration.

Authors:  Supanji Supanji; Dewi Fathin Romdhoniyyah; Muhammad Bayu Sasongko; Angela Nurini Agni; Firman Setya Wardhana; Tri Wahyu Widayanti; Muhammad Eko Prayogo; Ayudha Bahana Ilham Perdamaian; Aninditta Dianratri; Masashi Kawaichi; Chio Oka
Journal:  Clin Ophthalmol       Date:  2021-03-11

4.  Association of Serum Ferritin and Kidney Function with Age-Related Macular Degeneration in the General Population.

Authors:  Il Hwan Oh; Eun Young Choi; Joon-Sung Park; Chang Hwa Lee
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

5.  Gender-specific association of early age-related macular degeneration with systemic and genetic factors in a Japanese population.

Authors:  Mariko Sasaki; Sei Harada; Yumiko Kawasaki; Miki Watanabe; Hidemi Ito; Hideo Tanaka; Ayano Takeuchi; Kazuo Tsubota; Toru Takebayashi; Yuji Nishiwaki; Ryo Kawasaki
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

6.  Six-Year Incidence and Risk Factors of Age-Related Macular Degeneration in Singaporean Indians: The Singapore Indian Eye Study.

Authors:  Valencia Hui Xian Foo; Yasuo Yanagi; Quang Duc Nguyen; Charumathi Sabanayagam; Sing Hui Lim; Kumari Neelam; Jie Jin Wang; Paul Mitchell; Ching-Yu Cheng; Tien Yin Wong; Chui Ming Gemmy Cheung
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

7.  Real-Life Data of Patients with Exudative Age-Related Macular Degeneration.

Authors:  Mesut Togac; Ekrem Celik; Evrim Polat; Sibel Ahmet; Ahmet Alperen Koc; Zeynep Alkin
Journal:  Beyoglu Eye J       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.